Cargando…

Anti-Inflammatory Activities of Betulinic Acid: A Review

Inflammatory diseases have a high prevalence and has become of great interest due to the increase in life expectancy and the costs to the health care system worldwide. Chronic diseases require long-term treatment frequently using corticosteroids and non-steroidal anti-inflammatory drugs, which are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira-Costa, José Fernando, Meira, Cássio Santana, Neves, Maria Vitória Gomes das, Dos Reis, Bruna Padilha Zurita Claro, Soares, Milena Botelho Pereira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168372/
https://www.ncbi.nlm.nih.gov/pubmed/35677426
http://dx.doi.org/10.3389/fphar.2022.883857
_version_ 1784720994099789824
author Oliveira-Costa, José Fernando
Meira, Cássio Santana
Neves, Maria Vitória Gomes das
Dos Reis, Bruna Padilha Zurita Claro
Soares, Milena Botelho Pereira
author_facet Oliveira-Costa, José Fernando
Meira, Cássio Santana
Neves, Maria Vitória Gomes das
Dos Reis, Bruna Padilha Zurita Claro
Soares, Milena Botelho Pereira
author_sort Oliveira-Costa, José Fernando
collection PubMed
description Inflammatory diseases have a high prevalence and has become of great interest due to the increase in life expectancy and the costs to the health care system worldwide. Chronic diseases require long-term treatment frequently using corticosteroids and non-steroidal anti-inflammatory drugs, which are associated with diverse side effects and risk of toxicity. Betulinic acid, a lupane-type pentacyclic triterpene, is a potential lead compound for the development of new anti-inflammatory treatments, and a large number of derivatives have been produced and tested. The potential of betulinic acid and its derivatives has been shown in a number of pre-clinical studies using different experimental models. Moreover, several molecular mechanisms of action have also been described. Here we reviewed the potential use of betulinic acid as a promissory lead compound with anti-inflammatory activity and the perspectives for its use in the treatment of inflammatory conditions.
format Online
Article
Text
id pubmed-9168372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91683722022-06-07 Anti-Inflammatory Activities of Betulinic Acid: A Review Oliveira-Costa, José Fernando Meira, Cássio Santana Neves, Maria Vitória Gomes das Dos Reis, Bruna Padilha Zurita Claro Soares, Milena Botelho Pereira Front Pharmacol Pharmacology Inflammatory diseases have a high prevalence and has become of great interest due to the increase in life expectancy and the costs to the health care system worldwide. Chronic diseases require long-term treatment frequently using corticosteroids and non-steroidal anti-inflammatory drugs, which are associated with diverse side effects and risk of toxicity. Betulinic acid, a lupane-type pentacyclic triterpene, is a potential lead compound for the development of new anti-inflammatory treatments, and a large number of derivatives have been produced and tested. The potential of betulinic acid and its derivatives has been shown in a number of pre-clinical studies using different experimental models. Moreover, several molecular mechanisms of action have also been described. Here we reviewed the potential use of betulinic acid as a promissory lead compound with anti-inflammatory activity and the perspectives for its use in the treatment of inflammatory conditions. Frontiers Media S.A. 2022-05-23 /pmc/articles/PMC9168372/ /pubmed/35677426 http://dx.doi.org/10.3389/fphar.2022.883857 Text en Copyright © 2022 Oliveira-Costa, Meira, Neves, Dos Reis and Soares. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Oliveira-Costa, José Fernando
Meira, Cássio Santana
Neves, Maria Vitória Gomes das
Dos Reis, Bruna Padilha Zurita Claro
Soares, Milena Botelho Pereira
Anti-Inflammatory Activities of Betulinic Acid: A Review
title Anti-Inflammatory Activities of Betulinic Acid: A Review
title_full Anti-Inflammatory Activities of Betulinic Acid: A Review
title_fullStr Anti-Inflammatory Activities of Betulinic Acid: A Review
title_full_unstemmed Anti-Inflammatory Activities of Betulinic Acid: A Review
title_short Anti-Inflammatory Activities of Betulinic Acid: A Review
title_sort anti-inflammatory activities of betulinic acid: a review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168372/
https://www.ncbi.nlm.nih.gov/pubmed/35677426
http://dx.doi.org/10.3389/fphar.2022.883857
work_keys_str_mv AT oliveiracostajosefernando antiinflammatoryactivitiesofbetulinicacidareview
AT meiracassiosantana antiinflammatoryactivitiesofbetulinicacidareview
AT nevesmariavitoriagomesdas antiinflammatoryactivitiesofbetulinicacidareview
AT dosreisbrunapadilhazuritaclaro antiinflammatoryactivitiesofbetulinicacidareview
AT soaresmilenabotelhopereira antiinflammatoryactivitiesofbetulinicacidareview